Angela A. Armstrong

Array ( [id] => 7767861 [patent_doc_number] => 20120035111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Therapeutic Application of Adiponectin in Patients with Acute Myocardial Infarction' [patent_app_type] => utility [patent_app_number] => 12/713709 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3937 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035111.pdf [firstpage_image] =>[orig_patent_app_number] => 12713709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494507 [patent_doc_number] => 20100209502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Treatments Which Alleviate Functional Glycosylated Leptin Transport Factor for Controlling Weight and Obesity' [patent_app_type] => utility [patent_app_number] => 12/705872 [patent_app_country] => US [patent_app_date] => 2010-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12041 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209502.pdf [firstpage_image] =>[orig_patent_app_number] => 12705872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754797 [patent_doc_number] => 20120027843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'HB-EGF BOUND PROTEIN COMPLEX' [patent_app_type] => utility [patent_app_number] => 13/147903 [patent_app_country] => US [patent_app_date] => 2010-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15300 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027843.pdf [firstpage_image] =>[orig_patent_app_number] => 13147903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6230317 [patent_doc_number] => 20100184215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'MODIFIED THIOREDOXIN' [patent_app_type] => utility [patent_app_number] => 12/692912 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5120 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184215.pdf [firstpage_image] =>[orig_patent_app_number] => 12692912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8303395 [patent_doc_number] => 20120185955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'HEDGEHOG INHIBITOR ASSAY' [patent_app_type] => utility [patent_app_number] => 12/691800 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16681 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12691800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580850 [patent_doc_number] => 20110294733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'MODIFIED HUMAN THROMBOPOIETIN POLYPEPTIDE FRAGMENT AND MANUFACTURING METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 13/145513 [patent_app_country] => US [patent_app_date] => 2010-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21001 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294733.pdf [firstpage_image] =>[orig_patent_app_number] => 13145513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549283 [patent_doc_number] => 08324164 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Peptides and altered peptide ligands derived from HSP60 and pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 12/649687 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7918 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12649687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669033 [patent_doc_number] => 20110318302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 13/140150 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7852 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254846 [patent_doc_number] => 08618263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Antibodies against tissue factor pathway inhibitor (TFPI)' [patent_app_type] => utility [patent_app_number] => 13/140840 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13865 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6632954 [patent_doc_number] => 20100173408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Receptor-based interaction trap' [patent_app_type] => utility [patent_app_number] => 12/653484 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16730 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173408.pdf [firstpage_image] =>[orig_patent_app_number] => 12653484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535360 [patent_doc_number] => 08048986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Reversed mammalian protein-protein interaction trap' [patent_app_type] => utility [patent_app_number] => 12/653513 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9574 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048986.pdf [firstpage_image] =>[orig_patent_app_number] => 12653513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8981850 [patent_doc_number] => 08512964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Targets for treatment of hypercholesterolemia' [patent_app_type] => utility [patent_app_number] => 13/132296 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 58 [patent_no_of_words] => 33929 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8041409 [patent_doc_number] => 20120070443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'PDE1 AS A TARGET THERAPEUTIC IN HEART DISEASE' [patent_app_type] => utility [patent_app_number] => 13/132547 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21720 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070443.pdf [firstpage_image] =>[orig_patent_app_number] => 13132547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599580 [patent_doc_number] => 20100098624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'METHOD FOR USING CDO ANTAGONISTS TO MODULATE HEDGEHOG SIGNALING' [patent_app_type] => utility [patent_app_number] => 12/628895 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 63009 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098624.pdf [firstpage_image] =>[orig_patent_app_number] => 12628895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311568 [patent_doc_number] => 08652785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1' [patent_app_type] => utility [patent_app_number] => 13/131914 [patent_app_country] => US [patent_app_date] => 2009-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 20359 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13131914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711017 [patent_doc_number] => 20120003673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Screening method, composition containing substance selected by the screening method, and binding substance' [patent_app_type] => utility [patent_app_number] => 13/131339 [patent_app_country] => US [patent_app_date] => 2009-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5806 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13131339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6499669 [patent_doc_number] => 20100209958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'METHOD OF TREATING ARTHRITIS AND PROMOTING GROWTH OF ARTICULAR CHONDROCYTES' [patent_app_type] => utility [patent_app_number] => 12/623936 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14838 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209958.pdf [firstpage_image] =>[orig_patent_app_number] => 12623936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8183967 [patent_doc_number] => 20120114594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'MUSCLE REPAIR PROMOTER' [patent_app_type] => utility [patent_app_number] => 13/319570 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9122 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114594.pdf [firstpage_image] =>[orig_patent_app_number] => 13319570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499487 [patent_doc_number] => 20110262456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHOD OF TREATING ISCHEMIA REPERFUSION INJURY' [patent_app_type] => utility [patent_app_number] => 13/129230 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6190 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262456.pdf [firstpage_image] =>[orig_patent_app_number] => 13129230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234911 [patent_doc_number] => 20100266615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'D1-1 NUCLEIC ACIDS, POLYPEPTIDES AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 12/617170 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30511 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266615.pdf [firstpage_image] =>[orig_patent_app_number] => 12617170 [rel_patent_id] =>[rel_patent_doc_number] =>)